ARCHIVES

AACR Urges FDA To Speed Approval of Therapies for Precancerous Lesions

This article is from The Cancer Letter archive.

Vol. 28 No. 42 | November 15, 2002

Download PDF Visit The Full Archive

Related Articles

“Comprehensive” Tag For Centers A Poor Choice, Word-Conscious NCI Staff, Committee Feel

February 22, 1974

NCI Develops Plan For Specialized Centers, But Funding $67.5M Program Depends On New $$

July 5, 1991

NCI T Phase Out Support Of VA Lung Group, But Will Continue Funding VASAG

November 3, 1978

Vermont Cancer Center’s NCI Core Grant Renewed.

May 11, 2001

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

September 29, 2006

RFA On Natural Inhibitors Role In Prevention Released

April 2, 1982